Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Gastrointestinal Functional & Motility Disorders
•
Primary Care
Is there a particular prokinetic agent that you recommend if a patient has failed both PPI and TCA in the treatment of suspected functional dyspepsia?
Related Questions
How do you counsel a patient on returning to the care of their PCP when a workup for MCAS has been unrevealing, but the patient insists that they have a mast cell disorder because they respond to antihistamine therapy?
Are there data to support the use of herbal supplements, prebiotics, or probiotics in the management of SIBO?
Do 5HT4 agonists such as Metoclopramide actually lead to improvement in symptoms for patients with diabetes related gastroparesis?
Do you routinely check vitamin K levels in post-bariatric surgery patients?
When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?
How do you approach managing depression symptoms in patients who have had repeated high risk of bleeding?
Do you feel comfortable using Jak inhibitors in patients with a strong family history of CAD, but no other risk factors?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
What treatments have you found most effective for cholestatic pruritus?
Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?